An open-label trial to compare exposures of subcutaneous long-acting injectable use olanzapine (TV-44749) versus oral olanzapine in adults with schizophrenia (ORBIT).
Authors: Merenlender Wagner A, Shulman K, Gidron-Budovsky R, Elgart A, Jehassi A, Sharon N, Apolinario R, Davis G, Duma K, Suett M, Gutman D, Rabinovich-Guilatt L
Journal: European Psychiatry
mental health
psychology
open access